Severe fever with thrombocytopenia syndrome (SFTS) is an emerging tick-borne disease caused by the SFTS virus, posing significant public health challenges in East Asia. This study aimed to evaluate the seroprevalence of SFTS on Jeju Island, Korea, and to identify the demographic and geographic factors influencing exposure to the virus. A total of 1001 serum samples collected from healthy individuals between 2009 and 2016 were analyzed using a double-antigen enzyme-linked immunosorbent assay. The overall seroprevalence was 1.7%, with slightly higher rates observed in females (2.06%) than in males (1.29%); however, this difference was not statistically significant. Seroprevalence increased with age, peaking at 2.50% in individuals over aged 60 and over. Regional analysis revealed elevated seroprevalence in the eastern coastal areas (4.41%), which was attributed to population density and environmental factors favoring human–tick interactions. These findings suggest that population distribution and land use patterns, rather than altitude alone, significantly affect the exposure of SFTS on Jeju Island. Targeted tick control strategies and public health interventions that focus on high-risk regions and demographics could mitigate SFTS transmission. This study provides valuable insights into the epidemiological characteristics of SFTS and emphasizes the importance of tailored preventive measures in endemic regions.
Severe fever with thrombocytopenia syndrome (SFTS) is a tick-borne disease with a high mortality rate. While research has focused on high-risk rural populations and healthy individuals in endemic regions, such as Jeju Island, data on patients with underlying chronic diseases remain limited. This study aimed to evaluate the seroprevalence of SFTS virus (SFTSV) in patients with various chronic diseases across the Republic of Korea. Serum samples (n = 2948) collected from 10 regional biobanks between 2009 and 2019 were analyzed using a double-antigen sandwich enzyme-linked immunosorbent assay. The overall seroprevalence was 1.22% (36/2948). Seropositivity was significantly higher in males (1.73%) than in females (0.73%, p = 0.013) and increased with age (p = 0.001), peaking at 2.73% in individuals aged 70–79. Geographically, the highest rates were in Gyeongbuk (3.03%), Jeonnam (2.40%), and Gangwon (1.83%). Multivariable logistic regression showed older age (adjusted odds ratio 1.47 per 10-year increase, 95% confidence interval: 1.12–1.97) as the strongest independent predictor of seropositivity. Patients with hepatobiliary/pancreatic cancer (3.16%) and prostate cancer (2.50%) exhibited higher seroprevalence than those in other disease groups. SFTSV exposure is non-negligible among those with chronic diseases, particularly older males in rural provinces. Public health strategies should specifically address these vulnerable populations.
Daegu in the Republic of Korea experienced the 1st major community outbreak of coronavirus disease 2019 (COVID-19) outside China in February 2020. The infection fatality rate (IFR) and herd immunity level of COVID-19 in the early stages of the pandemic have not been thoroughly investigated in Korea. The aim of this study was to assess the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) seroprevalence and IFR prior to the introduction of COVID-19 vaccines. We conducted a seroprevalence survey in Daegu, using a convenience sample of residual serum specimens from 1500 individuals during August and September 2020. The serum specimens were provided by a commercial referral laboratory. The primary outcome measures were the seroprevalence of SARS-CoV-2 binding antibodies and neutralizing antibodies. The calculated case fatality rate (CFR) and IFR were secondary outcome measures. Of 1500 serum specimens tested for SARS-CoV-2 binding and neutralizing antibodies, the seroprevalences were 0.8% for binding antibodies and 0.3% for neutralizing antibodies. The estimated IFR (1.00%) and CFR (2.71%) for COVID-19 were significantly higher than the CFR for influenza in the Republic of Korea (0.03–0.18%). In September 2020, most Daegu residents had not developed antibodies against SARS-CoV-2, despite the major outbreak earlier that year. In the early stages of a major viral epidemic such as COVID-19, when herd immunity has not been established and vaccines and treatments are not yet available, rigorous contact tracing and isolation of those who are infected are crucial for containing the spread.